Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab... see more

TSX:MBX - Post Discussion

Microbix Biosystems Inc. > QAP's and related products
View:
Post by RazeKreations on Dec 04, 2020 6:24pm

QAP's and related products

Microbix currently has 66 different QAP products. 19 are Covid related 47 for various other conditions.  even when Covid gets under control ther will still need to be testing for it just like the annual flu bug. When the pandemic is under control all the other products will be more in demand as doctors and labs have more time and resources for those tests.  Back in June 27th 2007 Kinlytic was the big story and it drove MBX share price up to 1.60 and that was based purely on speculation. What is happening now is NOT speculative but real actual sales and production.  And then there is VTM wich is just exploding in demand and MBX has the credentials,ability and sales now.  The US market is estimated at 2.2 Billion dollars for VTM annualy and growing. Canada Market probably 10% of that. Then on top of that MBX has 30 different antigens products.  Start adding all that up and then you will realize that the current share price is dirt cheap. What is happening now far surpasses anything Kinlytic would do when you add it all together. 
VTM..........QAP's.............Antigens..........
Comment by RazeKreations on Apr 24, 2021 4:23pm
This is a post from Dec of last year Since then more Qaps and Antigens have been added along with the sales of DxTm
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities